Use of Ranibizumab With Mitomycin C During Trabeculectomy

Completed · Phase 1/Phase 2

Conditions studied: Glaucoma

In brief

The purpose of the study is to study the safety of the combination of ranibizumab and MMC vs monotherapy MMC vs intravitreal ranibizumab injection in patients with glaucoma.

Key facts

Study ID

NCT00661583

Run by

University of Colorado, Denver

People needed

30

Starts

2008-04-01

Expected to finish

2014-09-01

Last updated by the study team

2016-10-13

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• glaucoma
• undergoing trabeculectomy
• 21 years of age or older

You may not qualify if…

• pregnancy or lactation
• any condition the investigator believes would impose a significant hazard to the patient if investigational therapy were initiated
• history of ocular surface disease
• cataract surgery in the past 6 months
• history of active inflammatory, infectious or idiopathic keratitis

Where it is running

• Rocky Mountain Lions Eye Institute — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.